Australia & New Zealand Healthcare CROs Market Size, Share & Trends Analysis Report By Phase Type (Drug Discovery, Preclinical, Clinical), By Service, By Application, By End-use, By Country, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Research Methodology & Scope

• 1.1 Market Segmentation and Scope
• 1.2 Market Definitions
  • 1.2.1 Phase Type
  • 1.2.2 Service
  • 1.2.3 Application
  • 1.2.4 End Use
• 1.3 Research Methodology
• 1.4 Information Procurement
  • 1.4.1 Information analysis
  • 1.4.2 Market formulation & data visualization
  • 1.4.3 Data validation & publishing
• 1.5 Research Scope and Assumptions
  • 1.5.1 Commodity Flow Analysis
  • 1.5.2 Top-down market estimation
  • 1.5.3 Country-based segment share calculation
  • 1.5.4 Multivariate analysis
  • 1.5.5 Australia and New Zealand Healthcare CROs market: CAGR Calculation
• 1.6 List of Secondary Sources
• 1.7 List of Abbreviations
• 1.8 Objectives
  • 1.8.1 Objective - 1:
  • 1.8.2 Objective - 2:
  • 1.8.3 Objective - 3:
  • 1.8.4 Objective - 4:

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
  • 2.2.1 Segment snapshot (Phase type & application)
  • 2.2.2 Segment snapshot (Service)
  • 2.2.3 Segment snapshot (End-use)
• 2.3 Competitive Landscape Snapshot

Chapter 3 Australia & New Zealand Healthcare Contract Research Organizations Market: Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market
  • 3.1.2 Ancillary Market Outlook
• 3.2 Market Driver Analysis
  • 3.2.1 Market Driver IMPACT Analysis
    • 3.2.1.1 Increasing adoption of advanced technologies
    • 3.2.1.2 Rising strategic Competitive initiatives
    • 3.2.1.2.1 Geographical expansion
    • 3.2.1.2.2 Mergers and Acquisitions
    • 3.2.1.3 R&D Grants and Tax Incentives
    • 3.2.1.4 Cost-Effectiveness & Favorable environment for clinical trials
  • 3.2.2 Market Restraint Impact Analysis
    • 3.2.2.1 Quality Concerns in CRO services
    • 3.2.2.2 Intellectual property rights issues
• 3.3 Industry Analysis
  • 3.3.1 Porter's Five Forces Analysis
  • 3.3.2 PESTEL Analysis
• 3.4 Impact & Reformation By Covid-19
  • 3.4.1 Overall COVID-19 Impact
  • 3.4.2 COVID-19 impact on notable global market players that OPERATE in Australian and New Zealand Healthcare CROs Market
    • 3.4.2.1 IQVIA
    • 3.4.2.2 SYNEOS HEALTH
    • 3.4.2.3 ICON PLC
    • 3.4.2.4 LABCORP
    • 3.4.2.5 PPD (Thermo Fisher Scientific Inc.)
    • 3.4.2.6 CHARLES RIVER Laboratories
  • 3.4.3 PostCOVID-19 Impact on the Market

Chapter 4 Australia & New Zealand Healthcare CRO Market: Phase Type Segment Analysis

• 4.1 Australia & New Zealand Healthcare CRO: Market Share Analysis, 2022 & 2030
• 4.2 Australia and New Zealand Healthcare Contract Research Outsourcing Market, by Phase Type, 2018 - 2030 (USD Million)
• 4.3 Drug Discovery
  • 4.3.1 Target validation
  • 4.3.2 Lead identification
  • 4.3.3 Lead optimization
• 4.4 Preclinical
• 4.5 Clinical
  • 4.5.1 Phase I Trial Services
  • 4.5.2 Phase II Trial Services
  • 4.5.3 Phase III Trial Services
  • 4.5.4 Phase IV Trial Services

Chapter 5 Australia & New Zealand Healthcare CRO Market: Service Segment Analysis

• 5.1 Australia & New Zealand Healthcare CRO: Market Share Analysis, 2022 & 2030
• 5.2 Australia and New Zealand Healthcare Contract Research Outsourcing Market, by Services, 2018 - 2030 (USD Million)
• 5.3 Project Management/Clinical Supply Management
• 5.4 Data Management
• 5.5 Regulatory/Medical Affairs
• 5.6 Medical Writing
• 5.7 Clinical Monitoring
• 5.8 Quality Management/ Assurance
• 5.9 Bio-statistics
• 5.10 Investigator Payments
• 5.11 Laboratory
• 5.12 Patient and Site Recruitment
• 5.13 Technology Services
• 5.14 Other Services

Chapter 6 Australia & New Zealand Healthcare CRO Market: Application Segment Analysis

• 6.1 Australia & New Zealand Healthcare CRO: Market Share Analysis, 2022 & 2030
• 6.2 Australia and New Zealand Healthcare Contract Research Outsourcing Market, by Application, 2018 - 2030 (USD Million)
• 6.3 Oncology
• 6.4 Cardiovascular
• 6.5 Autoimmune/Inflammation
• 6.6 Central Nervous System (CNS)
• 6.7 Dermatology
• 6.8 Infectious Diseases
• 6.9 Respiratory
• 6.10 Others

Chapter 7 Australia & New Zealand Healthcare CRO Market: End-use Segment Analysis

• 7.1 Australia & New Zealand Healthcare CRO: Market Share Analysis, 2022 & 2030
• 7.2 Australia and New Zealand Healthcare Contract Research Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
• 7.3 Pharmaceutical & Biopharmaceutical Companies
• 7.4 Medical Device Companies

Chapter 8 Australia & New Zealand Healthcare CRO Market: Country Analysis

• 8.1 AUSTRALIA
  • 8.1.1 Key Country Dynamics
  • 8.1.2 Competitive Scenario
  • 8.1.3 Regulatory Framework
    • 8.1.3.1 Australia Healthcare CRO MARKET estimates and forecasts, 2018 - 2030 (USD Million)
• 8.2 New Zealand
  • 8.2.1 Key Country Dynamics
  • 8.2.2 Competitive Scenario
  • 8.2.3 Regulatory Framework
    • 8.2.3.1 New Zealand Healthcare CRO MARKET estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9 Australia & New Zealand Healthcare CRO Market: Competitive Landscape

• 9.1 Company Profile
  • 9.1.1 Paraxel International Corporation
    • 9.1.1.1 Company Overview
    • 9.1.1.2 Financial Performance
    • 9.1.1.3 Service Benchmarking
    • 9.1.1.4 Strategic Initiatives
  • 9.1.2 SGS SA
    • 9.1.2.1 Company Overview
    • 9.1.2.2 Financial Performance
    • 9.1.2.3 Service Benchmarking
    • 9.1.2.4 Strategic Initiatives
  • 9.1.3 ICON plc
    • 9.1.3.1 Company Overview
    • 9.1.3.2 Financial Performance
    • 9.1.3.3 Service Benchmarking
    • 9.1.3.4 Strategic Initiatives
  • 9.1.4 Thermo Fisher Scientific Inc. (PPD)
    • 9.1.4.1 Company Overview
    • 9.1.4.2 Financial Performance
    • 9.1.4.3 Service Benchmarking
    • 9.1.4.4 Strategic Initiatives
  • 9.1.5 Medpace Australia Pty. Ltd
    • 9.1.5.1 Company Overview
    • 9.1.5.2 Financial Performance
    • 9.1.5.3 Service Benchmarking
    • 9.1.5.4 Strategic Initiatives
  • 9.1.6 Charles River Laboratories International, Inc.
    • 9.1.6.1 Company Overview
    • 9.1.6.2 Financial Performance
    • 9.1.6.3 Service Benchmarking
    • 9.1.6.4 Strategic Initiatives
  • 9.1.7 IQVIA
    • 9.1.7.1 Company Overview
    • 9.1.7.2 Financial Performance
    • 9.1.7.3 Service Benchmarking
    • 9.1.7.4 Strategic Initiatives
  • 9.1.8 Novotech
    • 9.1.8.1 Company Overview
    • 9.1.8.2 Financial Performance
    • 9.1.8.3 Service Benchmarking
    • 9.1.8.4 Strategic Initiatives
  • 9.1.9 Laboratory Corporation of America Holdings
    • 9.1.9.1 Company Overview
    • 9.1.9.2 Financial Performance
    • 9.1.9.3 Service Benchmarking
    • 9.1.9.4 Strategic Initiatives
  • 9.1.10 Syneos Health
    • 9.1.10.1 Company Overview
    • 9.1.10.2 Financial Performance
    • 9.1.10.3 Service Benchmarking
    • 9.1.10.4 Strategic Initiatives
• 9.2 Company Heat Map Analysis
• 9.3 Strategy Mapping
  • 9.3.1 Expansion
  • 9.3.2 Mergers & acquisition
  • 9.3.3 Collaborations
  • 9.3.4 Partnership
  • 9.3.5 Others

List of Tables

• Table 1 Phase type segment definition
• Table 2 Service segment definition
• Table 3 Application segment definition
• Table 4 End use segment definition
• Table 5 List of secondary sources
• Table 6 List of abbreviations
• Table 7 Strategic collaborations by key players
• Table 8 Strategic partnerships with biopharmaceutical companies
• Table 9 Major acquisitions in the global CRO market in 2020 - 2021
• Table 10 Australia notable grants and incentives for R&D activities
• Table 11 Australia and New Zealand Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
• Table 12 Australia and New Zealand Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
• Table 13 Australia and New Zealand Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
• Table 14 Australia and New Zealand Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
• Table 15 Australia and New Zealand Healthcare Contract Research Outsourcing Market, by Application, 2018 - 2030 (USD Million)
• Table 16 Australia and New Zealand Healthcare Contract Research Outsourcing Market, by end-use, 2018 - 2030 (USD Million)
• Table 17 Clinical trial application requirements in Australia, U.S., and the EU
• Table 18 Main documents required for regulatory and ethics committee submissions

List of Figures

• Fig. 1 Australia and New Zealand Healthcare CRO market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Data Analysis Models
• Fig. 5 Market Formulation And Validation
• Fig. 6 Data Validating & Publishing
• Fig. 7 Commodity flow analysis
• Fig. 8 Segment snapshot (Phase type & application)
• Fig. 9 Segment snapshot (Service)
• Fig. 10 Segment snapshot ( End-use)
• Fig. 11 Healthcare Contract Research Outsourcing Market Value, 2022 (USD Million)
• Fig. 12 Ancillary Market Value, 2022 (USD Million)
• Fig. 13 Market trends and outlook
• Fig. 14 Total number of merger & acquisition deals and buyouts across global CROs & CDMOs (2016 - 2020)
• Fig. 15 Porter's five forces analysis
• Fig. 16 PEST Analysis
• Fig. 17 Australia & New Zealand Healthcare CRO market phase type outlook: Segment dashboard
• Fig. 18 Australia & New Zealand Healthcare CRO market: type movement analysis
• Fig. 19 Drug discovery market, 2018 - 2030 (USD Million)
• Fig. 20 Target validation market, 2018 - 2030 (USD Million)
• Fig. 21 Lead identification market, 2018 - 2030 (USD Million)
• Fig. 22 Lead optimization market, 2018 - 2030 (USD Million)
• Fig. 23 Preclinical market, 2018 - 2030 (USD Million)
• Fig. 24 Clinical market, 2018 - 2030 (USD Million)
• Fig. 25 Phase I trial services market, 2018 - 2030 (USD Million)
• Fig. 26 Phase II trial services market, 2018 - 2030 (USD Million)
• Fig. 27 Phase III trial services market, 2018 - 2030 (USD Million)
• Fig. 28 Phase IV trial services market, 2018 - 2030 (USD Million)
• Fig. 29 Australia & New Zealand Healthcare CRO market service outlook: Segment dashboard
• Fig. 30 Australia & New Zealand Healthcare CRO market: Service movement analysis
• Fig. 31 Project management/clinical supply management market, 2018 - 2030 (USD Million)
• Fig. 32 Parameters for measuring the success of provider solution
• Fig. 33 Data management market, 2018 - 2030 (USD Million)
• Fig. 34 Clinical data management flow
• Fig. 35 Regulatory/medical affairs market, 2018 - 2030 (USD Million)
• Fig. 36 Medical writing market, 2018 - 2030 (USD Million)
• Fig. 37 Clinical monitoring market, 2018 - 2030 (USD Million)
• Fig. 38 Quality management/ assurance market, 2018 - 2030 (USD Million)
• Fig. 39 Bio-statistics market, 2018 - 2030 (USD Million)
• Fig. 40 Investigator payments market, 2018 - 2030 (USD Million)
• Fig. 41 Laboratory market, 2018 - 2030 (USD Million)
• Fig. 42 Patient and site recruitment market, 2018 - 2030 (USD Million)
• Fig. 43 Strategic initiatives with a positive impact on patient recruitment
• Fig. 44 Technology services market, 2018 - 2030 (USD Million)
• Fig. 45 Other services market, 2018 - 2030 (USD Million)
• Fig. 46 Australia & New Zealand Healthcare CRO market application outlook: Segment dashboard
• Fig. 47 Australia & New Zealand Healthcare CRO market: application movement analysis
• Fig. 48 Oncology market, 2018 - 2030 (USD Million)
• Fig. 49 Cardiovascular market, 2018 - 2030 (USD Million)
• Fig. 50 Autoimmune/Inflammation market, 2018 - 2030 (USD Million)
• Fig. 51 Central nervous system (CNS) market, 2018 - 2030 (USD Million)
• Fig. 52 Dermatology market, 2018 - 2030 (USD Million)
• Fig. 53 Infectious diseases market, 2018 - 2030 (USD Million)
• Fig. 54 Respiratory market, 2018 - 2030 (USD Million)
• Fig. 55 Others market, 2018 - 2030 (USD Million)
• Fig. 56 Australia & New Zealand Healthcare CRO market end-use outlook: Segment dashboard
• Fig. 57 Australia & New Zealand Healthcare CRO market: end-use movement analysis
• Fig. 58 Pharmaceutical & biopharmaceutical companies market, 2018 - 2030 (USD Million)
• Fig. 59 Medical device companies market, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Site start-up timelines (public and private sites) in Australia (CTN scheme)
• Fig. 62 Timeline estimates for FIH trial completion in Australia compared to Europe and North America
• Fig. 63 Australia healthcare CRO market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Clinical trial approval procedure in NZ
• Fig. 66 New Zealand healthcare CRO market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Strategic framework